Can Lower Doses of Weight Loss Drugs Lower Costs?
Eli Lilly announced in a press release last week that it has reduced the prices of vials of its popular anti-obesity drug Zepbound and introduced new dosage options. The company is now offering 7.5 mg and 10 mg vials, higher doses than it’s offered since launching Zepbound vials in August. It’s also slashing the cost of 2 mg and 5 mg vials by $50 a month.
Like all of its Zepbound vials, the new dosages are available for eligible people who pay out of pocket through LillyDirect, the company’s direct-to-consumer website. To use the vials, people have to draw out the medicine with a syringe and inject themselves with a needle.
Before launching the Zepbound vials in 2024, Eli Lilly offered the drug only in a single-dose injector pen, used once weekly, in doses ranging from 2.5 mg to 15 mg.
Excerpted from Health
